Roflumilast Uses, Side Effects & Warnings - Drugs.com
2024年4月1日 · Roflumilast reduces inflammation in the lungs that leads to COPD (chronic obstructive pulmonary disease). Roflumilast is used to prevent worsening of symptoms in people with severe COPD. Roflumilast is not a bronchodilator and will not treat a bronchospasm attack that has already begun.
Roflumilast - Wikipedia
Roflumilast, sold under the brand name Daxas among others, is a medication used for the treatment of chronic obstructive pulmonary disease, [4] plaque psoriasis, [5] seborrheic dermatitis, [6] and atopic dermatitis. [5] It acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4). [10] It has anti-inflammatory effects ...
roflumilast oral: Uses, Side Effects, Interactions, Pictures
Roflumilast is used to control and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis).
DALIRESP® (roflumilast) – For Adults with Severe COPD
DALIRESP® (roflumilast) is a prescription medicine used in adults with severe COPD, to decrease the number of flare-ups or the worsening of COPD symptoms (exacerbations). Find more information about how DALIRESP can help you.
Roflumilast: a review of its use in the treatment of COPD - PMC
Roflumilast is a PDE4 inhibitor with demonstrated efficacy for improving lung function and decreasing exacerbations in patients with severe to very severe COPD associated with chronic bronchitis.
Roflumilast: MedlinePlus Drug Information
Roflumilast is used in people with severe chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways) to reduce the number of episodes or worsening of COPD symptoms. Roflumilast is in a class of medications called phosphodiesterase inhibitors. It works by decreasing swelling in the lungs.
Roflumilast (oral route) - Mayo Clinic
Roflumilast is used to prevent the symptoms (flare-ups) of chronic obstructive pulmonary disease (COPD). This medicine is available only with your doctor's prescription.
Daliresp: Uses, Dosage & Side Effects - Drugs.com
2024年4月8日 · Daliresp (roflumilast) prevents worsening of chronic obstructive pulmonary disease in people with severe COPD. Includes Daliresp side effects, interactions and indications.
Roflumilast: Uses, Interactions, Mechanism of Action - DrugBank …
Roflumilast is a selective phosphodiesterase-4 inhibitor indicated to decrease the risk of exacerbations in patients with severe chronic obstructive pulmonary disease (COPD) and to treat skin conditions such as plaque psoriasis and atopic dermatitis.
Daliresp (roflumilast): Side Effects, Uses, Dosage ... - RxList
2022年1月12日 · Daliresp (roflumilast) is a selective phosphodiesterase 4 (PDE4) inhibitor indicated as a treatment for chronic obstructive pulmonary disease (COPD) in patients who also suffer from chronic bronchitis. Daliresp is not a bronchodilator and is not indicated for the relief of acute bronchospasm. What Are Side Effects of Daliresp?